Abiopharma

Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Mountain Crest Acquisition 6 Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on June 22, 2026

NUBURU Presents NUBURU Defense Italian Plan and Strengthens Strategic Team Following Golden Power Notification

Businesses overestimate real progress on AI

Federated Hermes launches active ETF offering investors access to leading international companies

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum

Cerus Corporation - Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress

Jet.AI Issues Investor Guide on Proposed flyExclusive Merger Transaction

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

TechForce Robotics Advances Pharmaceutical Automation Initiative Through Phase 2 Deployment of PUR-E at SAPU Bio OEB-5 Sterile Injectable cGMP Facility